Brain-Controlled Spinal Stimulation Walking Therapy After Incomplete Spinal Cord Injury (SCI)

StatusActive, Not Recruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment closed, study ongoing Show 5 more changesShow less
    • Final enrollment: 6 participants (planned 12)
    • Interventions modified
    • Eligibility criteria expanded, about 24 words
    • Secondary endpoints: details revised at 6 of 8 entries
    • Site details revised
  2. Re-verified, no change to tracked fieldsv7
  3. Primary completion date: Oct 31, 2025 to Dec 31, 2026
    • Study completion date: Dec 31, 2025 to Dec 31, 2026
    v6
  4. Primary completion date: Jul 31, 2025 to Oct 31, 2025
    • Secondary endpoints: details revised at 8 of 8 entries
    • Site contact updated
    v5
  5. Site contact updated
    • Collaborators expanded, about 5 words
    v4
Show 2 earlier versionsHide 2 earlier versions
  1. Re-verified, no change to tracked fieldsv3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jul 31, 2024 to May 7, 2024
    • Eligibility criteria revised
    • Site details revised
    v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this research is to test the effectiveness of a new therapy, called Brain-Computer Interface (BCI)-Transcutaneous Spinal Cord Stimulation (TSCS), for improving walking in people with an incomplete spinal cord injury (SCI).
Trial Details
NCT Number NCT06406855
Lead Sponsor University of Miami
Collaborators: United States Department of Defense
Conditions
(from sponsor)		 Spinal Cord Injuries
Related terms Spinal Cord Injuries
Enrollment 6 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov